查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018753

开放式磁振造影系统市场：按组件、磁场强度、成像模式、应用和最终用户划分－2026年至2032年全球市场预测

Open MRI Systems Market by Component, Field Strength, Imaging Mode, Application, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，开放式 MRI 系统市值将达到 17.7 亿美元，到 2026 年将成长到 19.1 亿美元，到 2032 年将达到 31.2 亿美元，复合年增长率为 8.45%。

主要市场统计数据
基准年 2025 17.7亿美元
预计年份：2026年 19.1亿美元
预测年份 2032 31.2亿美元
复合年增长率 (%) 8.45%

对开放式 MRI 系统进行全面介绍，重点在于临床益处、以患者为中心、技术成熟度和操作注意事项。

开放式磁振造影(MRI) 系统代表着影像架构的重大变革，旨在提升病患舒适度、临床可及性和操作柔软性。与传统的封闭式磁振造影平台不同，开放式 MRI 解决方案优先考虑患者体验，透过减少恐惧症，并方便行动不便或体内植入医疗器材的患者进行检查。这些设计理念对临床工作流程、麻醉需求和放射科实验室容量有着显着的影响，尤其是在门诊、儿童和肌肉骨骼疾病诊疗领域。

分析了近期透过硬体进步、基于软体的影像重建、分散式医疗服务以及不断变化的患者期​​望等变革性变化，这些变化正在重塑开放式 MRI 系统。

开放式磁振造影系统正经历一场变革，其驱动力来自于技术进步、医疗服务模式的转变以及患者期望的不断提高。首先，梯度线圈工程和射频（RF）系统设计的改进显着提升了非常规磁铁配置的空间解析度和讯号杂讯比。这些硬体进步与影像重建、伪影抑制和自动化后处理方面的软体改进相辅相成，共同拓展了开放式平台的临床效用。

详细检验了美国累积关税措施在 2025 年如何重塑诊断影像系统的筹资策略、采购风险管理和成本弹性。

美国政策和贸易趋势为诊断成像平台的采购经济性和供应链策略带来了许多影响。到2025年，关税累积调整和进口限制的变化已经影响到进口零件和成品系统的成本结构，尤其是那些通常从全球供应商采购的子组件和磁性组件。随着关税措施的持续，许多相关人员正在透过重新评估供应商选择、增加库存缓衝以及探索替代货源来应对，以确保供应的连续性并控制价格波动风险。

将组件架构、磁场强度选择、成像模式、临床应用和最终用户优先顺序与实施和采购决策联繫起来的详细细分见解。

精细化的细分为临床和商业相关人员提供了观点，其中组件层面、磁场强度、成像模式、应用和最终用户等方面的差异都会影响采购和部署决策。基于组件层面的考虑，相关人员认识到线圈几何形状和射频链路设计的进步对影像保真度和协议柔软性有着显着影响，并评估梯度线圈、磁体、电源单元和射频系统的相对优势。这些组件层面的差异也会影响维修程序、备件策略以及生物医学团队的训练需求等方面的决策。

区域性洞察揭示了主要区域部署因素、法规环境和基础设施的差异如何影响开放式 MRI 部署策略。

区域趋势对美洲、欧洲、中东和非洲以及亚太地区开放式磁振造影技术的应用模式、监管考量和供应链策略有着至关重要的影响。在美洲，需求主要由大规模公立和私人医疗系统驱动，这些系统优先考虑患者体验、扩大门诊服务范围以及製定有利于临床应用的监管路径。该地区的资本规划往往需要在成本意识和以患者为中心的设施需求之间取得平衡，尤其是在竞争激烈的都市区市场，差异化能够显着影响转诊趋势。

对竞争因素进行策略性审查，展示产品工程、组件专业化、生命週期服务和伙伴关係关係如何定义开放式 MRI 系统的领导地位。

开放式磁振造影系统领域的竞争动态是由成熟的成像设备製造商、专业组件供应商和灵活的整合商共同塑造的，这些整合商弥合了硬体和软体能力之间的差距。将磁铁和梯度线圈的稳健工程设计与先进的射频管理和重建演算法相结合的製造商往往能赢得临床的广泛信赖。同时，提供创新梯度线圈、高效能电源单元和新一代射频链路的供应商在实现平台差异化方面发挥着至关重要的作用。

为产品模组化、整合软体开发、弹性供应链、增强型服务模式和以结果为导向的商业策略提供实用建议。

产业领导企业应优先考虑一系列切实可行的措施，使产品开发、商业策略和业务永续营运与不断变化的临床和法规环境保持一致。首先，投资于模组化平台架构，实现梯度组件、射频子系统和功率电子设备的逐步升级，从而延长使用寿命并减少整系统更换的需求。这种方法使医疗机构能够在保持技术先进性的同时，规划分阶段的资本投资。

我们高度透明的调查方法，结合了相关人员访谈、技术基准测试、第二手资料分析和基于情境的敏感度分析，得出了可靠的见解。

本分析所依据的研究结合了定性和定量方法，旨在全面且可重复地了解目前开放式磁振造影系统的现状。主要资讯来源包括对具有代表性的医疗服务机构中的临床负责人、生物医学工程师、采购负责人和服务经理进行的结构化访谈。除访谈外，分析还包括对组件架构的技术评估、公开的监管文件以及侧重于成像性能和患者预后的同行评审临床文献。

简明结论总结了开放式 MRI 平台的策略意义、技术进步、供应链挑战和实际实施考量。

开放式磁振造影系统在现代影像生态系统中扮演着日益重要且复杂多变的角色，它提供以患者为中心的多种选择，与不断发展的医疗服务模式相契合。梯度和射频设计方面的技术进步，以及重建软体的改进，缩小了效能差距，并扩大了临床应用范围。同时，供应链和政策压力凸显了製定稳健的筹资策略和高度灵活的服务提案的必要性，这些策略和方案应优先考虑长期营运的连续性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：开放式磁振造影系统市场：依组件划分

  • 梯度线圈
  • 磁铁
  • 电源单元
  • 高频系统

第九章：开放式磁振造影系统市场：依磁场强度划分

  • 高磁场强度
  • 低磁场强度
  • 中等磁场强度

第十章 开放式磁振造影系统市场：依影像模式划分

  • 二维成像
  • 三维成像

第十一章 开放式磁振造影系统市场：依应用领域划分

  • 乳房摄影
  • 心血管影像
  • 神经影像学
  • 脊椎和肌肉骨骼影像诊断

第十二章 开放式磁振造影系统市场：依最终用户划分

  • 门诊手术中心
  • 诊断中心
  • 医院
  • 研究机构

第十三章 开放式磁振造影系统市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 开放式磁振造影系统市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 开放式磁振造影系统市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国开放式磁振造影系统市场

第十七章：中国开放式磁振造影系统市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Alliance Medical Systems
  • ASG Superconductors spa
  • Barco NV
  • Beijing Wandong Medical Technology Co.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi Healthcare Manufacturing, Ltd.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Paramed Medical Systems, Inc.
  • Siemens AG
  • SternMed GmbH
  • VISION STAR PRIVATE LIMITED
Product Code: MRR-A26E0E57415E

The Open MRI Systems Market was valued at USD 1.77 billion in 2025 and is projected to grow to USD 1.91 billion in 2026, with a CAGR of 8.45%, reaching USD 3.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.77 billion
Estimated Year [2026] USD 1.91 billion
Forecast Year [2032] USD 3.12 billion
CAGR (%) 8.45%

A comprehensive introduction to open MRI systems highlighting clinical advantages, patient centricity, technological maturation, and operational considerations

Open magnetic resonance imaging (MRI) systems represent a purposeful shift in diagnostic imaging architecture designed to address patient comfort, clinical accessibility, and operational flexibility. Unlike conventional closed-bore platforms, open MRI solutions prioritize patient experience by reducing claustrophobia and enabling easier access for patients with mobility constraints or implanted devices. These design priorities translate into meaningful differences in clinical workflow, anesthetic needs, and the throughput profile of imaging suites, particularly in settings that emphasize outpatient, pediatric, and musculoskeletal care.

Technological maturity in coil design, magnet engineering, and radio frequency management has narrowed historical gaps in image fidelity between open and closed systems. As a result, clinicians can increasingly rely on open MRI for a broader range of diagnostic applications while benefitting from improved ergonomics. At the same time, service providers and health system planners evaluate open MRI on multiple operational axes: scan time efficiency, staff training requirements, integration with PACS and hospital information systems, and lifecycle serviceability. Therefore, decisions around adoption extend beyond clinical performance to encompass total cost of ownership drivers, site-specific throughput goals, and patient satisfaction metrics.

In this context, stakeholders must balance clinical requirements with capital planning, site constraints, and patient demographics. The introduction of novel component architectures and software-enabled image reconstruction has accelerated the pace at which open platforms can meet expanding clinical indications. Consequently, strategic conversations among clinical leaders, procurement teams, and technology providers are increasingly focused on the role of open MRI as a complement to, rather than a replacement for, high-field closed systems.

An analysis of recent transformative shifts reshaping open MRI systems through hardware advances, software reconstruction, decentralized care delivery, and evolving patient expectations

The landscape for open MRI systems is experiencing transformative shifts driven by converging technological advancements, changing care delivery models, and evolving patient expectations. First, improvements in gradient coil engineering and radio frequency (RF) system design have meaningfully enhanced spatial resolution and signal-to-noise ratio in non-traditional magnet configurations. These hardware gains are complemented by software advances in image reconstruction, artifact suppression, and automated post-processing, which together expand the clinical utility of open platforms.

Second, healthcare delivery is shifting toward ambulatory and decentralized models that prioritize shorter visits and higher patient throughput. As outpatient diagnostic centers proliferate, open MRI platforms that emphasize patient comfort and simplified access are gaining strategic relevance. This shift is reinforced by workforce considerations: technicians and radiologists are seeking systems that reduce positioning time and simplify protocol standardization across diverse patient populations.

Third, patient expectations are changing in ways that directly influence modality selection. A growing emphasis on patient experience metrics and consumer-style expectations for care environments means that imaging providers must weigh patient satisfaction as a factor in modality procurement. Open MRI's capacity to accommodate claustrophobic, pediatric, and bariatric patients without sedation aligns with these expectations and may reduce ancillary resource utilization.

Fourth, supply chain dynamics and component modularity are reshaping procurement and service models. Manufacturers are increasingly emphasizing modular components-such as separable gradient assemblies and swappable RF chains-that enable rapid upgrades and localized servicing. These modular approaches support longer equipment lifecycles and allow providers to phase capability enhancements without full platform replacement. Taken together, these shifts are redefining the competitive landscape for product developers, service partners, and health systems as they weigh investment priorities against clinical and operational outcomes.

A focused examination of how cumulative United States tariff actions through 2025 have reshaped sourcing strategies, procurement risk management, and cost resilience for diagnostic imaging systems

Policy and trade developments in the United States have introduced a range of considerations that influence procurement economics and supply chain strategies for diagnostic imaging platforms. Tariff adjustments and import regulatory changes that accumulated through 2025 have affected cost structures for imported components and finished systems, particularly for subassemblies and magnet elements often sourced across global suppliers. As tariffs have persisted, many stakeholders have responded by reassessing supplier footprints, increasing inventory buffers, and exploring alternative sourcing to stabilize supply continuity and manage price exposure.

These developments have prompted manufacturers and system integrators to accelerate supply chain de-risking, including qualifying secondary suppliers outside traditional sourcing regions and investing in nearshoring of critical components. Consequently, capital allocation decisions for product development and manufacturing expansion increasingly account for potential trade policy volatility. For health systems and diagnostic centers, procurement strategies have adapted to include lifecycle maintenance agreements and local service partnerships that can mitigate disruption risks associated with cross-border parts movement.

At the clinical operations level, the cumulative effect of tariff-driven input cost pressures has manifested in extended evaluation timelines for capital acquisitions and more rigorous total cost assessments during vendor selection. Vendors that demonstrate resilient logistics, transparent cost pass-through practices, and onshore stocking capabilities have seen improved receptivity among procurement committees. In summary, trade policy dynamics through 2025 have catalyzed a strategic shift from purely price-focused procurement toward an integrated resilience and value-based purchasing mindset that accounts for operational continuity and long-term serviceability.

Detailed segmentation insights that connect component architecture, field strength choices, imaging modes, clinical applications, and end-user priorities to deployment and procurement decisions

Granular segmentation provides the lens through which clinical and commercial stakeholders evaluate open MRI platforms, with component-level, field strength, imaging mode, application, and end-user distinctions each driving distinct procurement and deployment decisions. Based on component considerations, stakeholders assess the comparative advantages of gradient coils, magnets, power supply units, and radio frequency systems, recognizing that advances in coil geometry and RF chain design materially influence image fidelity and protocol flexibility. These component-level distinctions also inform maintenance regimes, spares strategy, and training requirements for biomed teams.

Field strength segmentation further differentiates platform selection along clinical performance and patient-safety lines. High field strength systems prioritize resolution for complex neurological and cardiovascular imaging, while low field strength systems emphasize safety for implanted device patients and operational simplicity. Mid field strength solutions often aim to balance these imperatives, offering an intermediate path that supports broader clinical indications without the infrastructure demands of the highest-field platforms.

Imaging mode distinctions, including 2D and 3D imaging capabilities, shape the clinical workflows and post-processing needs of imaging centers. Two-dimensional protocols remain prevalent for routine screening and follow-up examinations due to their speed and reduced computational overhead, while three-dimensional imaging is increasingly leveraged for advanced diagnostic tasks and surgical planning, particularly as reconstruction algorithms reduce acquisition time penalties.

Application-driven segmentation clarifies which clinical domains most readily benefit from open configurations. Breast imaging, cardiovascular imaging, neurological imaging, and spine and musculoskeletal imaging each present unique requirements in terms of coil design, patient positioning, and protocol optimization. Devices tailored for musculoskeletal and breast imaging often capitalize on targeted coils and shorter exam times, whereas neurological and cardiovascular applications demand higher spatial resolution and more sophisticated motion-management techniques.

Finally, end-user segmentation - spanning ambulatory surgical centers, diagnostic centers, hospitals, and research organizations - determines procurement cadence, service expectations, and capital deployment models. Ambulatory and diagnostic centers typically prioritize throughput and patient experience, hospitals focus on clinical breadth and interoperability with enterprise systems, and research organizations emphasize configurability and extensible hardware and software interfaces. Understanding how these segmentation axes interact allows stakeholders to map technology capabilities to real-world clinical and operational needs with greater precision.

Region-specific insights revealing how adoption drivers, regulatory environments, and infrastructural differences across major geographies influence open MRI deployment strategies

Regional dynamics exert a defining influence on adoption patterns, regulatory considerations, and supply chain strategies for open MRI technologies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, demand is shaped by large private and public health systems that emphasize patient experience, outpatient expansion, and regulatory pathways that facilitate clinical deployment. Capital planning in this region tends to balance cost sensitivity with the need for patient-centric amenities, particularly in competitive urban markets where differentiation can drive referral patterns.

Europe, the Middle East & Africa present a heterogenous landscape where reimbursement regimes, regulatory harmonization efforts, and infrastructural variability drive differentiated adoption trajectories. Western European markets typically prioritize integration with hospital IT ecosystems and adherence to rigorous clinical guidelines, while parts of the Middle East & Africa may emphasize infrastructure resilience and serviceability given regional logistical constraints. In these contexts, vendors that offer adaptable service models and strong local partnerships tend to secure enduring relationships with health systems and private providers.

Asia-Pacific encompasses a diverse set of market dynamics, including rapid clinical capacity expansion in urban centers, targeted investments in diagnostic infrastructure, and varying regulatory environments. Governments and large healthcare groups in the region often pursue capacity-building initiatives that favor scalable, cost-effective imaging solutions suitable for both tertiary hospitals and emerging outpatient networks. Across all regions, the interplay of reimbursement structures, workforce availability, and patient demographics shapes the relative attractiveness of open MRI deployments and the types of clinical use cases prioritized by providers.

A strategic review of competitive forces showing how product engineering, component specialization, lifecycle services, and partnerships define leadership in open MRI systems

Competitive dynamics in the open MRI systems arena are defined by a mix of established imaging OEMs, specialized component suppliers, and agile integrators that bridge hardware and software capabilities. Manufacturers that combine robust engineering for magnets and gradients with advanced RF management and reconstruction algorithms tend to command strong clinical credibility. At the same time, component vendors that supply gradient coil innovations, high-efficiency power supply units, and next-generation RF chains play a pivotal role in enabling platform differentiation.

Service and lifecycle management capabilities increasingly shape competitive positioning. Companies that provide predictable maintenance contracts, modular upgrade paths, and local service networks can reduce procurement friction for large health systems and outpatient chains. Moreover, firms that offer comprehensive training programs and streamlined adoption support for technologists and radiologists often achieve higher utilization and stronger client retention. Partnerships between component specialists and systems integrators can accelerate innovation cycles, while vertically integrated players that control magnet manufacturing and system assembly may capture efficiencies in lead times and serviceability.

Strategic collaborations with software vendors and clinical partners are another distinguishing feature among leading organizations. Those that invest in validated imaging protocols, evidence generation, and clinical training create a stronger value proposition for adoption across specialized applications such as neurological and musculoskeletal imaging. Ultimately, the competitive landscape rewards companies that balance engineering excellence with dependable post-sale support and adaptive commercialization models.

Actionable recommendations that guide product modularity, integrated software development, resilient supply chains, enhanced service models, and outcome-aligned commercial strategies

Industry leaders should prioritize a set of actionable measures that align product development, commercial strategy, and operational resilience to the evolving clinical and regulatory environment. First, invest in modular platform architectures that permit incremental upgrades to gradient assemblies, RF subsystems, and power electronics, thereby extending useful life and reducing the need for full-system replacement. This approach enables providers to plan phased capital investments while maintaining technological relevance.

Second, accelerate collaboration between hardware teams and software developers to optimize image reconstruction, artifact mitigation, and workflow automation. Integrated solutions that reduce exam times and simplify protocol standardization can materially improve throughput and staff productivity. In parallel, manufacturers should expand clinical validation programs that demonstrate equivalency or superiority in targeted applications such as musculoskeletal and breast imaging.

Third, develop resilient supply chain strategies that blend onshore stocking, multi-sourcing of critical components, and transparent cost pass-through mechanisms. Nearshoring of critical subassemblies where feasible can reduce exposure to tariff volatility and logistical disruption. Fourth, design service and training models that reduce the operational burden on clinical teams, including remote diagnostics, predictive maintenance analytics, and comprehensive onboarding curricula for technologists and radiologists.

Finally, deepen engagement with end-users through tailored financing options and outcome-aligned contracting that reflect the performance and utilization realities of open platforms. By aligning commercial structures with clinical and operational value, industry leaders can accelerate adoption while mitigating procurement friction and supporting sustained clinical integration.

A transparent research methodology combining stakeholder interviews, technical benchmarking, secondary document analysis, and scenario-based sensitivity assessments for robust insights

The research underpinning this analysis combines qualitative and quantitative techniques designed to produce a comprehensive and reproducible view of the open MRI systems landscape. Primary inputs include structured interviews with clinical leaders, biomedical engineers, procurement officers, and service managers across a representative set of healthcare delivery environments. These interviews were complemented by technical assessments of component architectures, publicly available regulatory filings, and peer-reviewed clinical literature focusing on imaging performance and patient outcomes.

Secondary inputs encompassed product technical specifications, published upgrade and maintenance protocols, and corporate disclosures on manufacturing footprints and service networks. Where appropriate, comparative technical benchmarking was applied to evaluate gradient coil performance, magnet homogeneity considerations, and radio frequency system efficiencies. Triangulation methods were used to reconcile insights from industry interviews with observed technical data, ensuring that conclusions rest on a robust evidentiary foundation.

Throughout the analysis, care was taken to assess the implications of trade and policy shifts through scenario-based sensitivity analyses rather than singular deterministic views. This methodological choice enables stakeholders to understand a range of plausible outcomes and to prioritize strategic responses that improve resilience. The research process emphasized transparency in assumptions, reproducibility of technical assessments, and validation against clinician feedback to ensure practical applicability.

A concise conclusion summarizing the strategic relevance of open MRI platforms, technological progress, supply chain imperatives, and practical adoption considerations

Open MRI systems occupy a growing and nuanced role within contemporary diagnostic imaging ecosystems by offering patient-centric alternatives that align with evolving care delivery models. Technological advances in gradient and RF design, coupled with improvements in reconstruction software, have narrowed performance differentials and expanded clinical applicability. At the same time, supply chain and policy pressures have highlighted the need for resilient sourcing strategies and adaptable service propositions that prioritize long-term operational continuity.

For clinical leaders, the decision to deploy open platforms requires a balanced assessment of application-specific performance, patient experience imperatives, and integration with broader imaging portfolios. For manufacturers and service providers, success depends on delivering modular, upgradeable platforms backed by comprehensive lifecycle support and validated clinical protocols. Looking ahead, the most successful stakeholders will be those who combine engineering innovation with pragmatic commercial terms and localized service footprints to meet the real-world demands of diverse healthcare settings.

In sum, open MRI systems are positioned not merely as a niche alternative but as a strategic complement to the imaging mix, especially where patient comfort, accessibility, and specific clinical indications align with the platform's strengths.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Open MRI Systems Market, by Component

  • 8.1. Gradient Coils
  • 8.2. Magnets
  • 8.3. Power Supply Units
  • 8.4. Radio Frequency System

9. Open MRI Systems Market, by Field Strength

  • 9.1. High Field Strength
  • 9.2. Low Field Strength
  • 9.3. Mid Field Strength

10. Open MRI Systems Market, by Imaging Mode

  • 10.1. 2D Imaging
  • 10.2. 3D Imaging

11. Open MRI Systems Market, by Application

  • 11.1. Breast Imaging
  • 11.2. Cardiovascular Imaging
  • 11.3. Neurological Imaging
  • 11.4. Spine & Musculoskeletal Imaging

12. Open MRI Systems Market, by End Users

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Diagnostic Centers
  • 12.3. Hospitals
  • 12.4. Research Organizations

13. Open MRI Systems Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Open MRI Systems Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Open MRI Systems Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Open MRI Systems Market

17. China Open MRI Systems Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alliance Medical Systems
  • 18.6. ASG Superconductors spa
  • 18.7. Barco N.V.
  • 18.8. Beijing Wandong Medical Technology Co.
  • 18.9. Bruker Corporation
  • 18.10. Canon Medical Systems Corporation
  • 18.11. Esaote S.p.A
  • 18.12. Fonar Corporation
  • 18.13. FUJIFILM Holdings Corporation
  • 18.14. GE HealthCare Technologies, Inc.
  • 18.15. Hitachi Healthcare Manufacturing, Ltd.
  • 18.16. Hologic, Inc.
  • 18.17. Koninklijke Philips N.V.
  • 18.18. Paramed Medical Systems, Inc.
  • 18.19. Siemens AG
  • 18.20. SternMed GmbH
  • 18.21. VISION STAR PRIVATE LIMITED

LIST OF FIGURES

  • FIGURE 1. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OPEN MRI SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL OPEN MRI SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GRADIENT COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GRADIENT COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GRADIENT COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MAGNETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MAGNETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MAGNETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY POWER SUPPLY UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY POWER SUPPLY UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY POWER SUPPLY UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RADIO FREQUENCY SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RADIO FREQUENCY SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RADIO FREQUENCY SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HIGH FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HIGH FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HIGH FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY LOW FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY LOW FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY LOW FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MID FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MID FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MID FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY BREAST IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY BREAST IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY BREAST IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY NEUROLOGICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY NEUROLOGICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY NEUROLOGICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY SPINE & MUSCULOSKELETAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY SPINE & MUSCULOSKELETAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY SPINE & MUSCULOSKELETAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 114. GCC OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. GCC OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 117. GCC OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. GCC OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 132. G7 OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. G7 OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 135. G7 OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. G7 OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 138. NATO OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. NATO OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 141. NATO OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NATO OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)